Araujo Healthcare Consulting: Driving Impact in Healthcare Policy, Compliance & Market Access

1️⃣ Pharmaceutical Advocacy & Market Access

Worked with Dr. Maeve O’Connor, a nationally recognized board-certified immunologist, to advocate for life-saving treatments in rare autoimmune diseases and biologic therapies.
Spearheaded market access strategies to secure insurance approvals and patient access to biologic therapies such as Xolair, Dupixent, Nucala, and Fasenra.
Navigated the complex landscape of clinical authorization and specialty pharmacy coordination, ensuring underserved patients received high-cost, high-impact treatments.
Developed case-based reimbursement appeals and medical necessity justifications to overturn denied claims, directly improving patient outcomes and physician prescribing power.

2️⃣ Regulatory Compliance & Policy Analysis

Provided strategic regulatory guidance to healthcare startups, pharmaceutical companies, and medical device firms navigating FDA, EMA, and global compliance frameworks.
Developed policy briefs addressing healthcare affordability, insurance barriers, and regulatory reform, influencing decision-makers and industry leaders.
Assisted in pre-market regulatory submissions for emerging biotech and med-tech companies, ensuring adherence to strict Good Manufacturing Practices and clinical trial regulations.
Designed compliance roadmaps for medical device companies expanding into European markets, aligning with CE marking requirements and Medical Device Regulation standards.

3️⃣ Grant Writing & Funding Strategy

Secured over $500K in funding for medical research organizations, rare disease initiatives, and healthcare startups through strategic grant writing and funding proposals.
Crafted compelling, data-driven grant applications that earned funding from health foundations, government research agencies, and biotech investors.
Advised nonprofits and early-stage health ventures on funding diversification, private-public grant strategies, and research proposal structuring.
Worked directly with leading rare disease research organizations, bridging the gap between scientific innovation, policy support, and funding acquisition.

4️⃣ Government & Policy Engagement

Committed to leveraging policy and legislative influence to improve healthcare accessibility, rare disease advocacy, and pharmaceutical innovation.
Actively building a network of policymakers, pharmaceutical leaders, and advocacy organizations to drive meaningful change in U.S. healthcare policy.
Researching lobbying pathways, public-private partnerships, and legislative frameworks to expand access to life-saving medications and influence pharmaceutical pricing structures.
Exploring opportunities to work with health committees, regulatory agencies, and advocacy coalitions to shape healthcare laws, drug affordability measures, and patient rights policies.

Araujo Healthcare Consulting bridges the gap between regulatory compliance, market access, policy advocacy, and funding strategies, helping clients overcome industry barriers and create scalable, sustainable healthcare solutions.

Want to collaborate or need expert insights? Let’s connect.